Smith & Nephew’s $240 Million Acquisition Of Integra LifeSciences

Jones Day advised Smith & Nephew plc, while Morgan Lewis advised Integra LifeSciences Holdings Corp. on the deal.

Smith & Nephew plc executed its acquisition of the extremity orthopedics business of Integra LifeSciences Holdings Corporation (NASDAQ: IART) for $240 million on a cash and debt-free basis.

The transaction includes the sale of Integra’s upper and lower extremity orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines.

Integra is a global medical technology company focused on regenerative technologies, neurosurgical, and extremity orthopedic solutions.

Headquartered in Watford, England, Smith & Nephew is a global medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services since 1856.

The Jones Day team advising Smith & Nephew was led by Kenneth Boehner (Picture).

Morgan Lewis team representing Integra included partners Benjamin Wills, Stephen Walters, and Charles Dauthier, and associates Conor Larkin, Robert Powers, and Victoria Régis.

Involved fees earner: Kenneth Boehner – Jones Day; Charles Dauthier – Morgan Lewis; Conor Larkin – Morgan Lewis; Robert Powers – Morgan Lewis; Victoria Régis – Morgan Lewis; Stephen Walters – Morgan Lewis; Benjamin Wills – Morgan Lewis;

Law Firms: Jones Day; Morgan Lewis;

Clients: Integra LifeSciences Holdings Corporation; Smith & Nephew plc;

Author: Ambrogio Visconti